Antimicrobial and Anesthetic Niosomal Formulations Based on Amino Acid-Derived Surfactants

• Published in: Molecules (Basel, Switzerland) Switzerland), 2024-06, Vol.29 (12), p.2843
• Main Authors: Romeo, Martina, Hafidi, Zakaria, Muzzalupo, Rita, Pons, Ramon, García, María Teresa, Mazzotta, Elisabetta, Pérez, Lourdes
• Format: Article
• Language: English
• Subjects: amino acid-based surfactant; Amino acids; Amino Acids - chemistry; Anesthetics - chemistry; Anesthetics - pharmacology; Anti-Infective Agents - chemistry; Anti-Infective Agents - pharmacology; Antibacterial agents; antimicrobial activity; Antimicrobial agents; Bacteria; Biodegradation; Drug Compounding; Drug delivery systems; Health aspects; High performance liquid chromatography; Liposomes - chemistry; Microbial Sensitivity Tests; Molecular Docking Simulation; Morphology; niosome; Phenylalanine; Surface active agents; Surface-Active Agents - chemistry; Surface-Active Agents - pharmacology; Surfactants; Transdermal medication
• ISSN: 1420-3049; 1420-3049
• DOI: 10.3390/molecules29122843

This work proposes the development of new vesicular systems based on anesthetic compounds (lidocaine (LID) and capsaicin (CA)) and antimicrobial agents (amino acid-based surfactants from phenylalanine), with a focus on physicochemical characterization and the evaluation of antimicrobial and cytotoxic properties. Phenylalanine surfactants were characterized via high-performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR). Different niosomal systems based on capsaicin, lidocaine, cationic phenylalanine surfactants, and dipalmitoyl phosphatidylcholine (DPPC) were characterized in terms of size, polydispersion index (PI), zeta potential, and encapsulation efficiency using dynamic light scattering (DLS), transmitted light microscopy (TEM), and small-angle X-ray scattering (SAXS). Furthermore, the interaction of the pure compounds used to prepare the niosomal formulations with DPPC monolayers was determined using a Langmuir balance. The antibacterial activity of the vesicular systems and their biocompatibility were evaluated, and molecular docking studies were carried out to obtain information about the mechanism by which these compounds interact with bacteria. The stability and reduced size of the analyzed niosomal formulations demonstrate their potential in pharmaceutical applications. The nanosystems exhibit promising antimicrobial activity, marking a significant advancement in pharmaceutical delivery systems with dual therapeutic properties. The biocompatibility of some formulations underscores their viability. The proposed niosomal formulations could constitute an important advance in the pharmaceutical field, offering delivery systems for combined therapies thanks to the pharmacological properties of the individual components.